Why the study?
Studies suggesting the benefit of albumin to enhance diuresis when loop diuretics alone fail are scarce, and co-administration of loop diuretics and albumin remains controversial.
Is baseline serum albumin level associated with 72-hour urine output in hospitalized heart failure patients receiving concomitant intravenous loop diuretics and albumin?
Is baseline serum albumin level associated with 72-hour urine output in hospitalized heart failure patients receiving concomitant intravenous loop diuretics and albumin?
Baseline serum albumin levels do not predict 72-hour urine output or weight loss in heart failure patients receiving concomitant albumin and loop diuretics, suggesting albumin levels should not guide this co-administration strategy.
Answers are grounded in this paper and cite their sources.
Baseline albumin should not yet guide albumin-diuretic co-administration in HF; leaves open whether this strategy benefits hypoalbuminemic patients.
Management of heart failure (HF) requires the use of loop diuretics to relieve congestion and improve symptoms. When loop diuretics alone fail to induce adequate diuresis, albumin has been proposed to enhance loop diuretic delivery and promote redistribution of fluid for excretion by the kidneys. Despite the theoretical benefits of albumin, studies suggesting its benefit in HF are scarce and the co-administration of loop diuretics and albumin remains controversial. This retrospective, observational study evaluated patients with HF 18 years or older who received concomitant intravenous loop diuretic and albumin administration. The primary objective was to evaluate the association of serum albumin level with urine output (UOP) in hospitalized patients with HF who received concomitant albumin and loop diuretic therapy. Secondary endpoints included total weight loss after 72 hours, and ICU and hospital lengths of stay. In total, 276 patients were included for analysis. There was no association between initial serum albumin level and 72-hour UOP (coefficient -623.1, 95% confidence interval -1558.6 to 312.4; P = 0.191) or weight difference at 72 hours (coefficient -1.0, 95% confidence interval -2.4 to 0.3; P = 0.131). Lower albumin levels were associated with longer ICU ( P = 0.034) and hospital ( P = 0.039) lengths of stay. Concomitant thiazide diuretic use and increasing loop diuretic doses were associated with increased 72-hour UOP. The results of our study suggests that providers should avoid using baseline albumin levels as guidance for albumin dosing in HF. Given the lack of comparator groups, larger randomized controlled trials should be done to provide a definitive role for albumin to enhance diuresis in patients with HF on intravenous loop diuretics.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: